241 related articles for article (PubMed ID: 1656540)
1. Beta-adrenergic receptor subtypes in the basal ganglia of patients with Huntington's chorea and Parkinson's disease.
Waeber C; Rigo M; Chinaglia G; Probst A; Palacios JM
Synapse; 1991 Aug; 8(4):270-80. PubMed ID: 1656540
[TBL] [Abstract][Full Text] [Related]
2. Loss of striatal histamine H2 receptors in Huntington's chorea but not in Parkinson's disease: comparison with animal models.
Martínez-Mir MI; Pollard H; Moreau J; Traiffort E; Ruat M; Schwartz JC; Palacios JM
Synapse; 1993 Nov; 15(3):209-20. PubMed ID: 7904088
[TBL] [Abstract][Full Text] [Related]
3. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
Huot P; Lévesque M; Parent A
Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
[TBL] [Abstract][Full Text] [Related]
4. Neurotensin receptor binding levels in basal ganglia are not altered in Huntington's chorea or schizophrenia.
Palacios JM; Chinaglia G; Rigo M; Ulrich J; Probst A
Synapse; 1991 Feb; 7(2):114-22. PubMed ID: 1672780
[TBL] [Abstract][Full Text] [Related]
5. Recent developments in Parkinson's disease and Huntington's chorea.
Barbeau A
Int J Neurol; 1976; 11(1):17-27. PubMed ID: 138661
[No Abstract] [Full Text] [Related]
6. Serotonin-1 receptor binding sites in the human basal ganglia are decreased in Huntington's chorea but not in Parkinson's disease: a quantitative in vitro autoradiography study.
Waeber C; Palacios JM
Neuroscience; 1989; 32(2):337-47. PubMed ID: 2531301
[TBL] [Abstract][Full Text] [Related]
7. Huntington's chorea. Changes in neurotransmitter receptors in the brain.
Enna SJ; Bird ED; Bennett JP; Bylund DB; Yamamura HI; Iversen LL; Snyder SH
N Engl J Med; 1976 Jun; 294(24):1305-9. PubMed ID: 4733
[TBL] [Abstract][Full Text] [Related]
8. Striatal calcium channel antagonist receptors in Huntington's disease and Parkinson's disease.
Watson DL; Carpenter CL; Marks SS; Greenberg DA
Ann Neurol; 1988 Mar; 23(3):303-5. PubMed ID: 2967667
[TBL] [Abstract][Full Text] [Related]
9. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
Sian J; Dexter DT; Lees AJ; Daniel S; Agid Y; Javoy-Agid F; Jenner P; Marsden CD
Ann Neurol; 1994 Sep; 36(3):348-55. PubMed ID: 8080242
[TBL] [Abstract][Full Text] [Related]
10. Excitatory amino acid binding sites in the caudate nucleus and frontal cortex of Huntington's disease.
Dure LS; Young AB; Penney JB
Ann Neurol; 1991 Dec; 30(6):785-93. PubMed ID: 1665055
[TBL] [Abstract][Full Text] [Related]
11. Adenosine A2 receptors: selective localization in the human basal ganglia and alterations with disease.
Martinez-Mir MI; Probst A; Palacios JM
Neuroscience; 1991; 42(3):697-706. PubMed ID: 1835521
[TBL] [Abstract][Full Text] [Related]
12. The relationships of aging changes in the basal ganglia to manifestations of Huntington's chorea.
Finch CE
Ann Neurol; 1980 May; 7(5):406-11. PubMed ID: 6446874
[No Abstract] [Full Text] [Related]
13. Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea.
Waters CM; Peck R; Rossor M; Reynolds GP; Hunt SP
Neuroscience; 1988 May; 25(2):419-38. PubMed ID: 2456487
[TBL] [Abstract][Full Text] [Related]
14. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease.
Bartzokis G; Tishler TA
Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):821-33. PubMed ID: 10875443
[TBL] [Abstract][Full Text] [Related]
15. Neurochemical substrates of rigidity and chorea in Huntington's disease.
Storey E; Beal MF
Brain; 1993 Oct; 116 ( Pt 5)():1201-22. PubMed ID: 7693298
[TBL] [Abstract][Full Text] [Related]
16. Distribution and modulation of histamine H(3) receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease.
Anichtchik OV; Peitsaro N; Rinne JO; Kalimo H; Panula P
Neurobiol Dis; 2001 Aug; 8(4):707-16. PubMed ID: 11493035
[TBL] [Abstract][Full Text] [Related]
17. Serotonin and dopamine striatal innervation in Parkinson's disease and Huntington's chorea.
Bédard C; Wallman MJ; Pourcher E; Gould PV; Parent A; Parent M
Parkinsonism Relat Disord; 2011 Sep; 17(8):593-8. PubMed ID: 21664855
[TBL] [Abstract][Full Text] [Related]
18. Neurotransmitter receptor alterations in Huntington's disease: autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes.
Whitehouse PJ; Trifiletti RR; Jones BE; Folstein S; Price DL; Snyder SH; Kuhar MJ
Ann Neurol; 1985 Aug; 18(2):202-10. PubMed ID: 2994554
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of handwriting of patients with Huntington's disease.
Phillips JG; Bradshaw JL; Chiu E; Bradshaw JA
Mov Disord; 1994 Sep; 9(5):521-30. PubMed ID: 7990847
[TBL] [Abstract][Full Text] [Related]
20. Regional specificity of brain atrophy in Huntington's disease.
Halliday GM; McRitchie DA; Macdonald V; Double KL; Trent RJ; McCusker E
Exp Neurol; 1998 Dec; 154(2):663-72. PubMed ID: 9878201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
